Unibest

Pharmaceutical intermediates

Apalutamide Intermediates

3 pharmaceutical intermediates for Apalutamide. Indication: Castration-resistant prostate cancer; Prostate cancer.

提交项目All intermediates

About Apalutamide

Originator
Janssen Biotech Inc
Indication
Castration-resistant prostate cancer; Prostate cancer
Approved Date
02/14/2018
DS/DP
03/27/2027

Available intermediates

3 intermediates currently listed for Apalutamide. Request specifications, documentation or a quotation for any item below.

Apalutamide intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
5-Amino-3-(trifluoromethyl)picolinonitrile573762-62-6//
N-Boc-1-aminocyclobutanecarboxylic acid120728-10-1//
1-amino-N-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]Cyclobutanecarboxamide1950587-17-3//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlfacalcidol

Building toward Apalutamide?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →